Developing gene therapy for head and neck cancer communicating bench to bedside
Clayman, G.L.
Acta Oto-Rhino-Laryngologica Belgica 53(3): 189
1999
ISSN/ISBN: 0001-6497 PMID: 10635390 Document Number: 503698
Document emailed within 1 workday
Related Documents
Woo, K.Thye.; Lau, Y.Kok.; Yap, H.Kim.; Lee, G.S.L.; Choong, H.Lin.; Vathsala, A.; Chiang, G.S.C.; Lee, E.J.C.; Wong, K.Seng.; Lim, C.Hong. 2006: 3rd College of Physicians' lecture--translational research: From bench to bedside and from bedside to bench; incorporating a clinical research journey in IgA nephritis (1976 to 2006) Annals of the Academy of Medicine Singapore 35(10): 735-741Tu, G.-y.; Xu, Z.-g.; Liu, S.-y. 2009: From head and neck surgery to head and neck oncology: the disciplinary guarantee for comprehensive cancer therapy Zhonghua Zhong Liu Za Zhi 31(11): 877-879
Grgić, M. 2000: Gene therapy of tumors of the head and neck: clinical use of the p53 tumor suppressor gene Lijecnicki Vjesnik 122(1-2): 14-16
Saito, H.; Ono, I.; Ebihara, S.; Yoshizumi, T.; Ikeda, S.; Ono, R. 1985: Cases of head and neck carcinoma detected by sputum cytology--lung cancer screening and head and neck cancer Gan no Rinsho. Japan Journal of Cancer Clinics 31(13): 1665-1668
Hoos, A.; Levey, D.L.; Lewis, J.J. 2004: Autologous heat shock protein-peptide complexes for vaccination against cancer: from bench to bedside Developments in Biologicals 116: 109-115; Discussion: 133-143
Federspil, P.; Elies, W.; Luckhaupt, H.; Marklein, G.; Mollenhauer, H.W.; Otten, J.E.; Otto, K.; Pelz, K.; Scholz, H.; Schrappe, M.; Seifert; Staib, A.H.; Straube, E.; Sybrecht, G.W.; Unertl, K. 2000: Antibiotic therapy for infections in the head and neck. German Society of Otorhinolaryngology, Head and Neck Surgery Hno 48(2): 91-103
Guo, W.; Qiu, W.L.; Zhang, Z.Y. 1998: Research advances in gene therapy of head and neck neoplasms: Literature review Shanghai Kou Qiang Yi Xue 7(2): 121-122
Liu, S.; Lin, Y.; Tang, S.; Yang, H.; Liang, C. 2001: IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma Hua Xi Kou Qiang Yi Xue Za Zhi 19(3): 191-193
Witt, R.; Schneider, C.; Raben, A.; Arm, R.; Kendall, J.; Symes, K.; Waddington, C.; Dolinger, E.; Casper, J.; Harrington, M. 2003: Head and neck cancer care in Delaware: the advent of the Helen F. Graham Head and Neck Multi-Disciplinary Center Delaware Medical Journal 75(12): 455-459
Sliwinski, T.; Markiewicz, L.; Rusin, P.; Pietruszewska, W.; Olszewski, J.; Morawiec-Sztandera, A.; Mlynarski, W.; Majsterek, I. 2009: Polymorphisms of the DNA base excision repair gene MUTYH in head and neck cancer Experimental Oncology 31(1): 57-59
Mao, L.; Fan, Y.H.; Lotan, R.; Hong, W.K. 1996: Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines Cancer Research 56(22): 5128-5131
Koscielny, S.; Dahse, R.; Sonntag, J.; Riese, U.; Theuer, C.; Hofmann, M.E.; von Eggeling, F.; Claussen, U.; Beleites, E.; Ernst, G.; Fiedler, W. 2000: Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer Otolaryngologia Polska 54(3): 291-295
Fujii, M. 2013: IV. Molecular targeting therapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 867-870
Tahara, M. 2012: II. Molecular targeting therapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(7): 1055-1060
Sakata, K-ichi. 2003: Evidence-based medicine (EBM) for radiation therapy--head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(3): 334-338
Kodaira, T. 2018: III. Current Status and Perspective of Radiation Therapy for Head and Neck Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(7): 1052-1055
Marcial, V.A.; Pajak, T.F.; Kramer, S.; Davis, L.W.; Stetz, J.; Laramore, G.E.; Jacobs, J.R.; Al-Sarraf, M.; Brady, L.W. 1988: Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer Seminars in Oncology 15(1): 39-60
Kawakami, T.; Watanabe, S.; Ogawara, T.; Akagi, S.; Tamura, S.; Koide, I.; Ogawa, A.; Takiguchi, S.; Masuda, Y. 1993: Etoposide, pirarubicin and cisplatin(ETP) combined therapy of inoperable head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(5): 669-672
Lertbutsayanukul, C.; Khorprasert, C.; Shotelersuk, K.; Jumpangern, C.; Sanghangthum, T.; Oonsiri, S.; Ayuthaya, I.Israngkul.Na.; Suriyapee, S.; Wadwongtham, W.; Supanakorn, S.; Kerekanjanarong, V.; Rojpornpradit, P. 2006: Intensity-modulated radiation therapy in head-and-neck cancer, first report in Thailand Journal of the Medical Association of Thailand 89(12): 2068-2076
Boeckxstaens, G.E. 2006: Neuroimmune interaction in the gut: from bench to bedside Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 68(5-6): 329-355